Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 16, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2020. Go to the latest filing (Q3 2026)

36.4B USDQ4 2020
Total value of stock positions
36.4B USD
Positions
96
Share of the ten largest
39.2%

The ten largest positions Q4 2020

  1. Microsoft 7.2%▲ +43.4%
  2. Bridgebio Pharma Inc 5.2%unchanged
  3. Adaptive Biotechnologies Cor 4.9%▼ −10.4%
  4. Fidelity National Information Services 4.6%▲ +33.2%
  5. T-Mobile US 3.2%▲ +7.9%
  6. Alphabet Inc. (Class A) 3.0%▲ +222.9%
  7. Boston Scientific 3.0%▲ +59.3%
  8. JPMorgan Chase 3.0%▼ −10.5%
  9. UnitedHealth Group 2.7%new
  10. Visa Inc. 2.5%▲ +1,170.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2020

Positions Q4 2020 per 13F filing, 41 of 41
Symbol Weight Shares Reported value Change Held since
Adaptive Biotechnologies Cor 4.9% 29,993,708 1.8B USD −10.4% reduced Q2 2019 7 quarters
JPM JPMorgan Chase 3.0% 8,459,075 1.1B USD −10.5% reduced Q1 2020 4 quarters
CNC Centene Corporation 2.2% 13,087,649 785.7M USD −25.0% reduced Q2 2018 11 quarters
Nuance Communications Inc 2.0% 16,382,663 722.3M USD −3.5% reduced Q2 2020 3 quarters
MELI MercadoLibre 1.9% 411,914 690.0M USD −13.0% reduced Q1 2019 8 quarters
AMZN Amazon 1.8% 200,471 652.9M USD −26.4% reduced Q2 2015 23 quarters
AXP American Express 1.7% 5,224,231 631.7M USD −51.8% reduced Q1 2020 4 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 1.7% 5,601,289 610.8M USD −8.9% reduced Q3 2020 2 quarters
AON Aon plc 1.5% 2,570,620 543.1M USD −14.7% reduced Q3 2018 10 quarters
HLT Hilton Worldwide 1.4% 4,719,901 525.1M USD −46.6% reduced Q2 2020 3 quarters
PH Parker Hannifin 1.3% 1,683,025 458.5M USD −33.2% reduced Q2 2020 3 quarters
Guardant Health Inc 1.3% 3,534,842 455.6M USD −8.3% reduced Q3 2019 6 quarters
BKNG Booking Holdings 1.2% 188,281 419.4M USD −46.0% reduced Q4 2019 5 quarters
CB Chubb Limited 1.1% 2,706,111 416.5M USD −20.8% reduced Q1 2020 4 quarters
AIZ Assurant 1.0% 2,758,595 375.8M USD −0.2% reduced Q2 2019 7 quarters
AMD Advanced Micro Devices 1.0% 4,015,000 368.2M USD −10.8% reduced Q3 2020 2 quarters
ALGN Align Technology 0.8% 534,944 285.9M USD −10.0% reduced Q2 2020 3 quarters
IR Ingersoll Rand 0.8% 6,145,201 280.0M USD −26.6% reduced Q1 2020 4 quarters
Encompass Health Corp 0.6% 2,643,276 218.6M USD −20.3% reduced Q1 2020 4 quarters
Molina Healthcare Inc 0.6% 1,022,739 217.5M USD −16.0% reduced Q3 2019 6 quarters
MU Micron Technology 0.6% 2,752,100 206.9M USD −11.7% reduced Q1 2020 4 quarters
Avalonbay Cmntys Inc 0.5% 1,209,895 194.1M USD −52.6% reduced Q3 2020 2 quarters
SNOW Snowflake 0.5% 627,157 176.5M USD −2.2% reduced Q3 2020 2 quarters
WDAY Workday, Inc. 0.5% 707,831 169.6M USD −37.0% reduced Q1 2020 4 quarters
LVS Las Vegas Sands 0.5% 2,826,560 168.5M USD −67.1% reduced Q1 2020 4 quarters
BMY Bristol Myers Squibb 0.4% 2,506,793 155.5M USD −21.4% reduced Q3 2020 2 quarters
Pmv Pharmaceuticals Inc 0.4% 2,364,062 145.4M USD −10.5% reduced Q3 2020 2 quarters
DRI Darden Restaurants 0.4% 1,070,370 127.5M USD −25.5% reduced Q2 2020 3 quarters
Pvh Corporation 0.2% 827,892 77.7M USD −53.0% reduced Q2 2020 3 quarters
CSGP CoStar Group 0.2% 70,949 65.6M USD −76.4% reduced Q3 2020 2 quarters
COO Cooper Companies (The) 0.1% 149,000 54.1M USD −57.6% reduced Q1 2020 4 quarters
EG Everest Group 0.1% 199,505 46.7M USD −69.8% reduced Q2 2020 3 quarters
TMO Thermo Fisher Scientific < 0.1% 77,817 36.2M USD −94.3% reduced Q2 2020 3 quarters
Gohealth Inc < 0.1% 2,600,905 35.5M USD −44.5% reduced Q3 2020 2 quarters
Karuna Therapeutics Inc < 0.1% 338,200 34.4M USD −49.1% reduced Q3 2020 2 quarters
Blueprint Medicines Corp < 0.1% 272,681 30.6M USD −80.9% reduced Q3 2018 10 quarters
Viela Bio Inc < 0.1% 703,424 25.3M USD −16.6% reduced Q4 2019 5 quarters
Laboratory Corp Amer HLDGS < 0.1% 94,500 19.2M USD −78.0% reduced Q3 2020 2 quarters
Chindata Group HLDGS Ltd < 0.1% 739,798 17.7M USD −50.0% reduced Q3 2020 2 quarters
Genmab A/S < 0.1% 377,562 15.4M USD −0.2% reduced Q3 2019 6 quarters
Bristol-Myers Squibb Co < 0.1% 8,825,899 6.1M USD −52.0% reduced Q4 2019 5 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 19.1%
  • Technology 15.3%
  • Health Care 13.5%
  • Communication Services 9.1%
  • Industrials 5.5%
  • Consumer Discretionary 5.4%
  • Materials 0.5%
  • Real Estate 0.2%
  • not in our coverage 31.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close